Originally published byDW News
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?
🇩🇪
More news from GermanyGermany
EUROPE
Related News
Iran war: Oil stocks being used up at record pace, IEA warns
1d ago
Cem Özdemir, first German state premier with Turkish roots
1d ago
Satellites add a new layer to global poverty data
2d ago
US-China summit could reshape global power
2d ago
Bodies of three women recovered from sea off Brighton
2d ago